BR100 Increased By (0.44%)
BR30 Increased By (1.39%)
KSE100 Increased By (0.62%)
KSE30 Increased By (0.61%)
BECO 5.43 Decreased By ▼ -0.06 (-1.09%)
BML 55.69 Decreased By ▼ -1.07 (-1.89%)
BOP 35.38 Increased By ▲ 0.26 (0.74%)
CNERGY 8.20 Increased By ▲ 0.05 (0.61%)
DCL 11.55 Increased By ▲ 0.04 (0.35%)
FCCL 58.36 Increased By ▲ 1.61 (2.84%)
FCSC 5.12 Decreased By ▼ -0.03 (-0.58%)
FFL 17.84 Decreased By ▼ -0.04 (-0.22%)
FNEL 1.25 No Change ▼ 0.00 (0%)
HUMNL 11.07 Decreased By ▼ -0.05 (-0.45%)
KEL 8.75 Increased By ▲ 0.33 (3.92%)
KOSM 6.69 Increased By ▲ 0.11 (1.67%)
MLCF 107.15 Increased By ▲ 3.85 (3.73%)
NBP 201.73 Increased By ▲ 1.55 (0.77%)
PACE 11.30 Increased By ▲ 0.01 (0.09%)
PAEL 44.49 Increased By ▲ 1.02 (2.35%)
PIAHCLA 29.41 Increased By ▲ 1.92 (6.98%)
PIBTL 18.64 Increased By ▲ 0.94 (5.31%)
PPL 247.98 Increased By ▲ 3.66 (1.5%)
PRL 35.29 Decreased By ▼ -0.14 (-0.4%)
PTC 66.14 Increased By ▲ 0.79 (1.21%)
SEARL 95.49 Increased By ▲ 2.17 (2.33%)
SSGC 32.04 Decreased By ▼ -0.90 (-2.73%)
TELE 8.87 Decreased By ▼ -0.04 (-0.45%)
THCCL 66.61 Decreased By ▼ -0.11 (-0.16%)
TPLP 10.57 Decreased By ▼ -0.26 (-2.4%)
TREET 25.30 Increased By ▲ 0.18 (0.72%)
TRG 64.40 Decreased By ▼ -0.50 (-0.77%)
WAVES 10.90 Decreased By ▼ -0.03 (-0.27%)
WTL 1.26 Increased By ▲ 0.01 (0.8%)
Pakistan

SHC directs govt to fix price of COVID-19 vaccine

  • On March 18, the court had suspended the drug regulatory authority’s notification concerning the withdrawal of exemption in Covid-19 vaccines import to a private pharma company
  • DRAP counsel requested the court to not allow the sale of the vaccine until its price is fixed
Published March 31, 2021 Updated March 31, 2021 11:48am

(Karachi) The Sindh High Court (SHC) has directed the federal government to fix the price of the coronavirus vaccine imported by the private sector in a week, local media reported Wednesday.

As per details, a two-member bench comprising Justice Muhammad Ali Mazhar and Justice Amjad Ali Sahito disposed of an appeal of the Drug Regulatory Authority of Pakistan (DRAP) that challenged a single bench’s March 18 verdict.

On March 18, the court had suspended the drug regulatory authority’s notification concerning the withdrawal of exemption in Covid-19 vaccines import to a private pharma company.

The firm’s lawyer stated before the court that the DRAP allowed the import of vaccine under certain conditions on February 2, following which the pharma company imported one million doses of Russia’s Sputnik-V vaccine.

He lamented that the firm is not being allowed to sell the vaccine. “We have already invested $45 million and imported the vaccine. What should we do now?” he asked.

A DRAP counsel requested the court to not allow the sale of the vaccine until its price is fixed.

Comments

Comments are closed for this article.